Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Profound Medical Corp T.PRN

Alternate Symbol(s):  PROF

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed... see more

Recent & Breaking News (TSX:PRN)

Profound Medical Corp. Announces $20 Million Bought Deal Financing

Canada NewsWire February 27, 2018

Profound Medical to Participate in 2018 BTIG Healthcare Conference

GlobeNewswire February 26, 2018

Profound Medical Corp. Announces Completion of Patient Enrollment in TACT Pivotal Clinical Trial  

GlobeNewswire January 31, 2018

Profound Medical Corp. Announces Preliminary Fourth Quarter 2017 Revenue and Provides Progress Update on TACT Pivotal Trial Patient Enrollment

GlobeNewswire January 8, 2018

Profound Medical Corp. to Present at the 29th Annual Piper Jaffray Healthcare Conference

GlobeNewswire November 14, 2017

Profound Medical Corp. Announces Third Quarter 2017 Financial Results

GlobeNewswire November 7, 2017

Investor Network Invites You to the Profound Medical Corp. Third Quarter 2017 Earnings Conference Call and Webcast Live on Tuesday, November 7, 2017

Accesswire November 6, 2017

Profound Medical Corp. Announces Expanded Clinical Use of TULSA-PRO® in Prostate Care to Include BPH

GlobeNewswire November 6, 2017

Profound Medical Corp. to Present at the 2017 Canaccord Genuity Medical Technologies & Diagnostics Forum

GlobeNewswire October 26, 2017

Profound Medical Corp. to Release Third Quarter 2017 Financial Results on November 7, 2017 – Conference Call to Follow

GlobeNewswire October 25, 2017

Profound Medical Corp. Announces Closing of $10 Million “Bought Deal” Financing

GlobeNewswire September 20, 2017

Profound Medical Corp. Announces $10 Million “Bought Deal” Financing

GlobeNewswire August 24, 2017

Profound Medical Announces Second Quarter 2017 Financial Results

GlobeNewswire August 23, 2017

Investor Network Invites You to the Profound Medical Corp. Second Quarter 2017 Earnings Conference Call and Webcast Live on Wednesday, August 23, 2017

Accesswire August 23, 2017

Profound Medical Corp. to Release Second Quarter 2017 Financial Results on August 23, 2017 – Conference Call to Follow

GlobeNewswire August 9, 2017

Profound Medical Corp. Completes Acquisition of Royal Philips’ Sonalleve MR-HIFU Business

GlobeNewswire July 31, 2017

IIROC Trading Resumption - PRN

Canada NewsWire June 30, 2017

IIROC Trade Resumption - Profound Medical Corp.

Newsfile June 30, 2017

Profound Medical Corp. Announces Definitive Agreement with Royal Philips to Expand Collaboration and Acquire Sonalleve MR-HIFU Business

GlobeNewswire June 30, 2017

IIROC Trade Halt - Profound Medical Corp.

Newsfile June 30, 2017